Improving early breast cancer detection: Focus on methylation

K. P.M. Suijkerbuijk, P. J. van Diest, E. van der Wall

Research output: Contribution to journalReview articlepeer-review

Abstract

The need for additional breast cancer screening tools is indisputably high, as one may conclude from the high rate of interval malignancies in women undergoing regular screening. DNA promoter methylation frequently occurs during breast carcinogenesis and is an early event in this process. Moreover, a field defect for methylation has been described and methylation values can reliably be assessed in limited amounts of DNA. Simultaneous detection of methylation of a panel of genes in breast fluids and/or blood derivatives could be both sufficiently specific and sensitive to be of additive value to current imaging-based screening methods. This review describes the recent developments in methylation detection in breast fluids, serum and plasma that paved the way for large prospective studies. These studies will provide us with the definite answer as to what will be the additive value of defining the methylation status of specific genes to current imaging-based screening methods.

Original languageEnglish (US)
Pages (from-to)24-29
Number of pages6
JournalAnnals of Oncology
Volume22
Issue number1
DOIs
StatePublished - Jan 2011

Keywords

  • Breast neoplasms
  • DNA methylation
  • Early detection of cancer
  • Nipple aspirate fluid
  • Plasma
  • Serum

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Improving early breast cancer detection: Focus on methylation'. Together they form a unique fingerprint.

Cite this